URINARY HEMOPEXIN AS A MARKER OF LUPUS ACTIVITY AMONG EGYPTIAN SLE PATIENTS WITH PROLIFERATIVE LUPUS NEPHRITIS

被引:0
|
作者
Sabry, Alaa [1 ]
Mahmoud, Rasha [1 ]
机构
[1] Mansoura Nephrol & Dialysis Unit, Dept Nephrol, Mansoura, Egypt
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO142
引用
收藏
页码:I82 / I84
页数:3
相关论文
共 50 条
  • [21] Effect of cyclophosphamide or azathioprine on urinary podocytes in patients with diffuse proliferative lupus nephritis
    Nakamura, T
    Ushiyama, C
    Shimada, N
    Sekizuka, K
    Ebihara, I
    Hara, M
    Koide, H
    NEPHRON, 2001, 87 (02): : 192 - 193
  • [22] Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis
    Daleboudt, G. M. N.
    Broadbent, E.
    Berger, S. P.
    Kaptein, A. A.
    LUPUS, 2011, 20 (03) : 290 - 298
  • [23] Serum and urinary IL-18 levels are associated with SLE and lupus nephritis activity
    Howe, H. S.
    Kong, K. O.
    Thong, B. Y. T.
    Lian, T. Y.
    Chng, H. H.
    Koh, E. T.
    Law, W. G.
    Leung, B. P. L.
    IMMUNOLOGY, 2012, 137 : 587 - 587
  • [24] Interleukin-34 as a marker for subclinical proliferative lupus nephritis
    Abdel-Rehim, Asmaa S. M.
    Mohamed, Nesrine A.
    Shakweer, Marwa M.
    LUPUS, 2020, 29 (06) : 607 - 616
  • [25] Serum and urinary IL-18 levels are associated with activity of SLE and lupus nephritis
    Howe, H. S.
    Kong, K. O.
    Thong, Bernard Y. H.
    Lian, T. Y.
    Chng, H. H.
    Koh, E. T.
    Law, W. G.
    Lau, T. C.
    Yong, W. H.
    Cheng, Y. K.
    Teh, C. L.
    Badsha, Humeira
    Leong, K. P.
    Leung, Bernard P. L.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S564 - S565
  • [26] Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus
    Fayed, Ahmed
    Mohamed, AbdelAal
    Ahmed, Reham Abdelghany
    Abouzeid, Sameh
    Soliman, Ahmed
    Fathy, Ahmed
    LUPUS, 2021, 30 (10) : 1631 - 1636
  • [27] Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
    Lindsey E Romick-Rosendale
    Hermine I Brunner
    Michael R Bennett
    Rina Mina
    Shannen Nelson
    Michelle Petri
    Adnan Kiani
    Prasad Devarajan
    Michael A Kennedy
    Arthritis Research & Therapy, 13
  • [28] HEPARANASE AS A NOVEL MARKER OF LUPUS NEPHRITIS ACTIVITY
    Szymczak, Maciej
    Kuzniar, Jakub
    Kopec, Waclaw
    Marchewka, Zofia
    Klinger, Marian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 182 - 183
  • [29] Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
    Romick-Rosendale, Lindsey E.
    Brunner, Hermine I.
    Bennett, Michael R.
    Mina, Rina
    Nelson, Shannen
    Petri, Michelle
    Kiani, Adnan
    Devarajan, Prasad
    Kennedy, Michael A.
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (06)
  • [30] PROINFLAMMATORY CYTOKINES (TNF alpha and IL-6) IN EGYPTIAN SLE PATIENTS WITH LUPUS NEPHRITIS Is it correlated with disease activity?
    Sabry, Alaa A.
    Kalil, Abdalla M.
    El-Rahim, Mona Abd
    El-Shahat, Fagr Bazyeed
    Elbasyouni, Sherief Refat
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2005, 2 (04): : 153 - 158